Join the Fluzone group to help and get support from people like you.
Fluzone News (Page 3)
Universal Flu Vaccine Blocks Infection in Mice
THURSDAY, Aug. 22, 2024 – A universal flu vaccine that would protect against all influenza strains – and that people might not need to take every year – could be close at hand, researchers report....
CureVac’s Coronavirus Vaccine at the Center of a Fight for Control
CureVac, a German biopharmaceutical company, has hit the headlines after US President Trump tried to secure exclusive rights to its developmental coronavirus vaccine. The vaccine is being developed...
FDA Approves Fluzone High-Dose Quadrivalent (Influenza Vaccine) for Adults 65 Years of Age and Older
PARIS, Nov. 4, 2019 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone High-Dose Quadrivalent (Influenza Vaccine) for...
Sanofi Pasteur Announces FDA Approval Of Fluzone Intradermal Quadrivalent
SWIFTWATER, Pa., Dec. 12, 2014 /PRNewswire/ – Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that the U.S. Food and Drug Administration (FDA) has...
New Fluzone Quadrivalent Four-Strain Influenza Vaccine from Sanofi Pasteur Now Licensed By FDA for Broad Age Range of Children and Adults
• The first and only 4-strain influenza vaccine option for patients as young as six months of age, • Helps protect children and adults against additional influenza B strain, • Newes...
FDA Licenses Fluzone Intradermal - Sanofi Pasteur's New Influenza Vaccine Delivered by Intradermal Microinjection
Swiftwater, Pa — May 10, 2011 /PRNewswire/ — Sanofi Pasteur, the vaccines division of Sanofi announced today the U.S. Food and Drug Administration (FDA) has approved the company's supplemental bio...